Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.160
+0.180 (4.52%)
At close: Jun 3, 2026, 4:00 PM EDT
4.170
+0.010 (0.24%)
After-hours: Jun 3, 2026, 4:10 PM EDT
Camp4 Therapeutics Employees
Camp4 Therapeutics had 48 employees as of December 31, 2025. The number of employees decreased by 7 or -12.73% compared to the previous year.
Employees
48
Change (1Y)
-7
Growth (1Y)
-12.73%
Revenue / Employee
$81,958
Profits / Employee
-$1,797,938
Market Cap
216.01M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 48 | -7 | -12.73% |
| Dec 31, 2024 | 55 | -9 | -14.06% |
| Sep 30, 2024 | 53 | -11 | -17.19% |
| Jun 30, 2024 | 58 | - | - |
| Dec 31, 2023 | 64 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Nkarta | 108 |
| Foghorn Therapeutics | 106 |
| Keros Therapeutics | 87 |
| Compugen | 75 |
| Fulcrum Therapeutics | 55 |
| Enlivex | 34 |
| Elicio Therapeutics | 33 |
CAMP News
- 13 days ago - CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 20 days ago - CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder - GlobeNewsWire
- 27 days ago - Camp4 Therapeutics reports Q1 EPS (32c), consensus (21c) - TheFly
- 27 days ago - CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights - GlobeNewsWire
- 27 days ago - Camp4 Therapeutics Quarterly report: Q1 2026 - Filings
- 27 days ago - Camp4 Therapeutics Earnings release: Q1 2026 - Filings
- 5 weeks ago - CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation - GlobeNewsWire
- 5 weeks ago - Camp4 Therapeutics Proxy statement: Proxy filing - Filings